Cargando…
Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
Nonalcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes mellitus (T2DM) have highly related mechanisms. Ramulus Mori (Sangzhi) alkaloids (SZ-A) from Morus alba L. were approved in 2020 for the treatment of T2DM. In this study, we examined the therapeutic effects and mechanism of SZ-A...
Autores principales: | Chen, Yan-Min, Lian, Chun-Fang, Sun, Qian-Wen, Wang, Ting-Ting, Liu, Yuan-Yuan, Ye, Jun, Gao, Li-Li, Yang, Yan-Fang, Liu, Shuai-Nan, Shen, Zhu-Fang, Liu, Yu-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137915/ https://www.ncbi.nlm.nih.gov/pubmed/35624769 http://dx.doi.org/10.3390/antiox11050905 |
Ejemplares similares
-
Ramulus Mori (Sangzhi) Alkaloids Ameliorate Obesity-Linked Adipose Tissue Metabolism and Inflammation in Mice
por: Sun, Qian-Wen, et al.
Publicado: (2022) -
Pharmacokinetics and tissue distribution of Ramulus Mori (Sangzhi) alkaloids in rats and its effects on liver enzyme activity
por: Liu, Zhihua, et al.
Publicado: (2023) -
Ramulus mori (Sangzhi) alkaloids regulates gut microbiota disorder and its metabolism profiles in obese mice induced by a high-fat diet
por: Liu, Dongdong, et al.
Publicado: (2023) -
Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
por: Liu, Quan, et al.
Publicado: (2021) -
Integration of Transcriptomics and Lipidomics Profiling to Reveal the Therapeutic Mechanism Underlying Ramulus mori (Sangzhi) Alkaloids for the Treatment of Liver Lipid Metabolic Disturbance in High-Fat-Diet/Streptozotocin-Induced Diabetic Mice
por: Wang, Fan, et al.
Publicado: (2023)